Skip to content
lifestyle.thedailyhaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biomea Fusion, Inc.
Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights
May 22, 2026
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions
May 21, 2026
Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment
April 29, 2026
Biomea Fusion to Participate at Upcoming Investor Conferences
February 19, 2026
←
Previous Page
1
2